May 11, 2018
Josh Mandel, health IT ecosystem lead at Verily, talks with Health 2.0 co-founder Matthew Holt about the evolution of healthcare applications and their broad adoption by EHR vendors.
May 10, 2018
Dan Gottleib, who leads the Smart Health IT project at Boston Children's, and Verily's Josh Mandel talk about FHIR, SMART and the concept of "substitute ability" as a means to improve interoperability.
May 2, 2018
Now the Health IT lead at Alphabet subsidiary Verily, Dr. Joshua Mandel was part of the team that created SMART Health IT, the open, standards-based platform that many health developers now use to build apps. But all that started when he got sick of some grunt work he was assigned as a medical student. Mandel told the story at Dev4Health at the HIMSS Innovation Center in Cleveland this week,...
December 21, 2017
While many of its health-related efforts have been shunted into Verily, Alphabet (the company formerly known as Google) actually made health-related moves across its business this year. From search engine updates to massive research studies to M&A, read on for a timeline of Alphabet subsidiaries’ biggest digital health moves this year.
January 26: Verily, Alphabet’s main healthcare subsidiary...
November 29, 2017
A slew of digital diabetes care companies have announced integrations with the upcoming virtual Type 2 diabetes management platform being developed by Onduo, a joint venture of Verily and Sanofi. These announced services include Voluntis’ Insulia, a digital insulin dose recommendation and coaching system; Glytec’s Glucommander Outpatient, cloud-based software that evaluates blood glucose and...
November 8, 2017
Now that the Abbott Freestyle Libre has received FDA clearance, Abbott and Dexcom will be forced into tight competition in the US market. On Dexcom’s third quarter call, CEO Kevin Sayer spent some time assuaging investor fears about that friction.
“Late in the third quarter, the FDA approved Abbott's FreeStyle Libre flash glucose monitoring system,” Sayer said on the call. “We always believed the...
October 3, 2017
All of the diverse operations of Verily, the life sciences technology company that began its life as Google X Life Sciences, can be summed up with a simple sentence: We should be treating our bodies at least as well as we treat our cars.
At the Health 2.0 Fall Conference in Santa Clara this week, Verily Chief Technology Officer Brian Otis spoke with Health 2.0 cofounder and CEO Dr. Indu Subaya on...
September 26, 2017
Just two months after announcing the applications for its pre-certification program pilot, the FDA has announced the nine companies that will be participating. The list includes major tech companies Apple and Samsung; health tech companies Verily, Pear Therapeutics, Tidepool, and Phosphorus; pharmaceutical companies Roche and Johnson & Johnson; and Fitbit — an interesting inclusion insofaras...
August 7, 2017
The University of North Carolina is tapping Google's Verily Life Sciences and MindStrong (the company for which Dr. Thomas Insell recently left Verily) for an ambitious 19-site study of post-traumatic stress disorder. The study, called the Aurora Study, is funded by a $21 million NIH grant and aims to enroll 5,000 people.
Aurora was launched last September and has sought private funding to...
August 3, 2017
DexCom hasn’t been shy about its plan for opening up the CGM market by encouraging CGM use in a wider group of people with diabetes — including, eventually, people with Type 2 diabetes. On its second quarter earnings call, the company went deep on that focus on the future.
“More and more people with diabetes are adopting CGM that as the primary tool to manage their condition, especially as we...